FastProbe® is a next-generation FISH probe technology designed to dramatically shorten hybridization time while maintaining high sensitivity, specificity, and signal quality. By leveraging non-repetitive DNA sequence design, FastProbe® enables same-day FISH reporting for routine clinical workflows.
Key Applications - Solid tumor cytogenetics (e.g., HER2, ALK, ROS1, MET) - Hematologic malignancies (e.g., AML1/ETO, PML/RARA) - Oncology and hematology research and clinical diagnostics
Core Advantages - Ultra-fast hybridization: 1 hour (blood/cell samples), 2 hours (tissue samples) - Same-day results: Final report available within one working day (<8 hours) - High sensitivity & specificity: Optimized probe design minimizes false negatives and false positives - Low background noise: Clear signal interpretation without ambiguity - Excellent anti-fading performance: Supports prolonged slide observation and re-reading
Clinical & Operational Value - Reduces turnaround time by up to 70–80% compared with conventional overnight FISH - Increases laboratory throughput by 2–5× within the same working day - Enables flexible scheduling (fast or overnight hybridization options) - Improves patient care through faster therapeutic decision-making
Quality & Compliance - CE-marked probes - ISO 13485 & ISO 9001 certified manufacturing